Biostage, Inc. (BSTG)
| Market Cap | 35.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.94M |
| Shares Out | 9.69M |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 229 |
| Open | 3.63 |
| Previous Close | 4.04 |
| Day's Range | 3.63 - 3.66 |
| 52-Week Range | 1.00 - 4.49 |
| Beta | -0.25 |
| Analysts | n/a |
| Price Target | 3.00 (-18.0%) |
| Est. Earnings Date | Nov 11, 2021 |
About BSTG
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is head...
Financial Performance
Financial StatementsNews
Biostage™ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Cli...
HOLLISTON, Mass., Sept. 8, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing novel organ regeneration technology based its patented Cel...
Biostage Reports Q2 2021 Financial Results
HOLLISTON, Mass., Aug. 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellfr...
Biostage Reports Q1 2021 Financial Results
HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellfra...
Biostage Reports 2020 Financial Results and Appointment of Interim Vice President of Finance
HOLLISTON, Mass., April 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing next-generation bioengineered esophageal implants, today a...